Cyclic changes in serum levels of insulin-like growth factor binding protein-1 in women treated with clomiphene citrate and tamoxifen

Gynecological Endocrinology

Volumn 14, Issue 4, 2000, Pages 236-244

  Wang, H S ^a   Wang, T H ^a   Soong, Y K ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Clomiphene citrate; Insulin like growth factor binding proteins (IGFBPs); Insulin like growth factor I (IGF I); Menstrual cycle; Tamoxifen

Indexed keywords

ANTIESTROGEN; CLOMIFENE CITRATE; ESTRADIOL; INHIBIN A; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TAMOXIFEN;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; OVARY FOLLICLE DEVELOPMENT; OVULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0033789877     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513590009167687     Document Type: Article

References (39)

1. Insulin-like growth factors: Autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments
2. Isolation and molecular cloning of insulin-like growth factor-binding protein-6
3. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-1 and -II
4. Chromatographic characterization of insulin-like growth factor-binding proteins in human pregnancy serum
5. Insulin-like growth factor (IGF) and IGF-binding proteins: Comparison of human serum and lymph
6. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries
7. Serum levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 and -3 in women with regular menstrual cycles
8. Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle
9. Insulin-like growth factor binding protein-1 and ovarian stimulation
10. IGFs and IGF-binding proteins in the regulation of human ovarian and endometrial function
11. Differential expression of messenger ribonucleic acids encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua
12. Insulin-like growth factor binding protein-1 in human endometrial function
13. Clomiphene citrate: Mechanism(s) and site(s) of action - A hypothesis revised
14. The agonisticantagonistic properties of clomiphene: A review
15. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists
16. Purification and assay of insulin-like growth factor-binding protein-1: Measurement of circulating levels throughout pregnancy
17. Insulin-like growth factor binding protein-1 inhibits the DNA amplification induced by insulin-like growth factor I in human granulosaluteal cells
18. Follicular fluid levels of insulin-like growth factor-I, insulin-like growth factor binding protein-1 and ovarian steroids collected during ovum pick-up
19. Insulin-like growth factor-binding protein-1 in human follicular fluid: A marker for oocyte maturation
20. Puberty and polycystic ovarian syndrome: The insulin/insulin-like growth factor I hypothesis
21. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein
22. Radiommunoassay of a 26,000-dalton plasma insulin-like growth factor binding protein: Control by nutritional variables
23. The production of progesterone, androgens and estrogens by granulosa cells, theca tissue and stromal tissue from human ovaries in vitro
24. Secretion of 'inhibin' by rat granulosa cells in vitro
25. Plasma inhibin levels during gonadotropin-induced ovarian hyperstimulation for IVF: A new index of follicular function?
26. Action of tamoxifen on folliculogenesis in the menstrual cycle of infertile patients
27. Luteotropic effects of tamoxifen in infertile women
28. Late luteal phase dydrogesterone in combination with clomiphene or tamoxifen in the treatment of infertility associated with irregular and infrequent menstruation: Enhancing patient compliance
29. Tamoxifen: An alternative approach in clomiphene resistant polycystic ovary syndrome patients
30. Tamoxifen treatment in women with failure of clomiphene citrate therapy
31. A clomiphene citrate and tamoxifen citrate combination therapy: A novel therapy for ovulation induction
32. Circulating immunoreactive inhibin levels during the normal human menstrual cycle
33. The isolation and physiology of inhibin and related proteins
34. Effects of aging on the human ovary: The secretion of immunoreactive α-inhibin and progesterone
35. Midluteal immunoreactive α-inhibin serum concentrations as markers of luteal phase deficiency
36. Inhibins, activins, and follistatins: Gonadal proteins modulating the secretion of follicle-stimulating hormone
37. Serum and follicular fluid levels of insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle
38. Alterations in the insulin-like growth factor system during the menstrual cycle in normal women